These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 28005690

  • 1. Low Bone Mineral Density in Vertically HIV-infected Children and Adolescents: Risk Factors and the Role of T-cell Activation and Senescence.
    Jiménez B, Sainz T, Díaz L, Mellado MJ, Navarro ML, Rojo P, González-Tomé MI, Prieto L, Martínez J, de José MI, Ramos JT, Muñoz-Fernandez MÁ, Madrid Cohort of HIV-Infected Children and Adolescents Integrated in the Pediatric Branch of the Spanish National AIDS Research Network (CoRISpe).
    Pediatr Infect Dis J; 2017 Jun; 36(6):578-583. PubMed ID: 28005690
    [Abstract] [Full Text] [Related]

  • 2. Factors associated with low bone mineral density in a Brazilian cohort of vertically HIV-infected adolescents.
    Schtscherbyna A, Pinheiro MF, Mendonça LM, Gouveia C, Luiz RR, Machado ES, Farias ML.
    Int J Infect Dis; 2012 Dec; 16(12):e872-8. PubMed ID: 23031418
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. CD4 T cell count is inversely associated with lumbar spine bone mass in HIV-infected men under the age of 50 years.
    Kwak MK, Lee EJ, Park JW, Park SY, Kim B-, Kim TH, Suh K, Koh J-, Lee SH, Byun D-.
    Osteoporos Int; 2019 Jul; 30(7):1501-1510. PubMed ID: 30915506
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Adverse bone health and abnormal bone turnover among perinatally HIV-infected Asian adolescents with virological suppression.
    Sudjaritruk T, Bunupuradah T, Aurpibul L, Kosalaraksa P, Kurniati N, Prasitsuebsai W, Sophonphan J, Sohn AH, Ananworanich J, Puthanakit T, Bone-D Study Group.
    HIV Med; 2017 Apr; 18(4):235-244. PubMed ID: 27477214
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Bone mineral density in children and adolescents with perinatal HIV infection.
    DiMeglio LA, Wang J, Siberry GK, Miller TL, Geffner ME, Hazra R, Borkowsky W, Chen JS, Dooley L, Patel K, van Dyke RB, Fielding RA, Gurmu Y, Jacobson DL, Pediatric HIVAIDS Cohort Study (PHACS).
    AIDS; 2013 Jan 14; 27(2):211-20. PubMed ID: 23032412
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Bone mineral density among children living with HIV failing first-line anti-retroviral therapy in Uganda: A sub-study of the CHAPAS-4 trial.
    Natukunda E, Szubert A, Otike C, Namyalo I, Nambi E, Bamford A, Doerholt K, Gibb DM, Musiime V, Musoke P.
    PLoS One; 2023 Jan 14; 18(7):e0288877. PubMed ID: 37471330
    [Abstract] [Full Text] [Related]

  • 12. Association between bone mineral density and content and physical growth parameters among children and adolescents diagnosed with HIV: a cross-sectional study.
    Zanlorenci S, Martins PC, Alves Junior CAS, Castro JAC, Lima LRA, Petroski EL, Silva DAS.
    Sao Paulo Med J; 2022 Jan 14; 140(5):682-690. PubMed ID: 35920531
    [Abstract] [Full Text] [Related]

  • 13. Prevalence and risk factors for low bone mineral density in antiretroviral therapy-naive HIV-infected young men.
    Paccou J, Viget N, Drumez E, Cortet B, Robineau O.
    Med Mal Infect; 2018 Oct 14; 48(7):442-448. PubMed ID: 29699830
    [Abstract] [Full Text] [Related]

  • 14. Impact of tenofovir disoproxil fumarate on bone metabolism and bone mass among perinatally HIV-infected Asian adolescents.
    Sudjaritruk T, Bunupuradah T, Aurpibul L, Kosalaraksa P, Kurniati N, Sophonphan J, Ananworanich J, Puthanakit T, Bone-D study group.
    Antivir Ther; 2017 Oct 14; 22(6):471-479. PubMed ID: 27786155
    [Abstract] [Full Text] [Related]

  • 15. Prevalence of bone mineral density abnormalities and related risk factors in an ambulatory HIV clinic population.
    Guillemi S, Harris M, Bondy GP, Ng F, Zhang W, Lima VD, Michaels CE, Belzberg A, Montaner JS.
    J Clin Densitom; 2010 Oct 14; 13(4):456-61. PubMed ID: 20663695
    [Abstract] [Full Text] [Related]

  • 16. Morphologic and metabolic abnormalities in vertically HIV-infected children and youth.
    Aldrovandi GM, Lindsey JC, Jacobson DL, Zadzilka A, Sheeran E, Moye J, Borum P, Meyer WA, Hardin DS, Mulligan K, Pediatric AIDS Clinical Trials Group P1045 team.
    AIDS; 2009 Mar 27; 23(6):661-72. PubMed ID: 19279441
    [Abstract] [Full Text] [Related]

  • 17. Total body and spinal bone mineral density across Tanner stage in perinatally HIV-infected and uninfected children and youth in PACTG 1045.
    Jacobson DL, Lindsey JC, Gordon CM, Moye J, Hardin DS, Mulligan K, Aldrovandi GM, Pediatric AIDS Clinical Trials Group P1045 team.
    AIDS; 2010 Mar 13; 24(5):687-96. PubMed ID: 20168204
    [Abstract] [Full Text] [Related]

  • 18. Bone mineral density and vitamin D concentration: the challenges in taking care of children and adolescents infected with HIV.
    Carmo FB, Terreri MT, Succi RCM, Beltrão SV, Gouvea AFTB, Paulino ERC, Machado DM.
    Braz J Infect Dis; 2017 Mar 13; 21(3):270-275. PubMed ID: 28399423
    [Abstract] [Full Text] [Related]

  • 19. Increased risk factors associated with lower BMD in antiretroviral-therapy-naïve HIV-infected adult male.
    Atencio P, Cabello A, Conesa-Buendía FM, Pérez-Tanoira R, Prieto-Pérez L, Carrillo I, Álvarez B, Arboiro-Pinel R, Díaz-Curiel M, Herrero-Beaumont G, Mediero A, Górgolas M.
    BMC Infect Dis; 2021 Jun 09; 21(1):542. PubMed ID: 34107907
    [Abstract] [Full Text] [Related]

  • 20. [Evaluation of bone mineral density in children with vertical infection by HIV].
    Torrejón C, Galaz MI, Vizueta E, Álvarez AM, Wu E, Chávez A, Villarroel J, Yohannessen K, Hevia M, Vivanco M, Rivero C, Balboa P.
    Rev Chilena Infectol; 2018 Jun 09; 35(6):634-641. PubMed ID: 31095183
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.